Blenrep 50 mg/mL
belantamab mafodotin · INJECTION, POWDER, FOR SOLUTION · GlaxoSmithKline LLC
Blenrep is a injection, powder, for solution containing belantamab mafodotin at 50 mg/mL, taken intravenous. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Blenrep
- Generic Name
- belantamab mafodotin
- NDC Code (Product)
0173-0913- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 50 mg/mL
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761440
- Marketing Start
- 10/23/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Blenrep used for?
Blenrep contains belantamab mafodotin. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is Blenrep a controlled substance?
Blenrep is not classified as a controlled substance by the DEA.
What is the generic name for Blenrep?
The generic name for Blenrep is belantamab mafodotin. There are no other listed brand versions of belantamab mafodotin.
What is the NDC code for Blenrep 50 mg/mL?
The NDC (National Drug Code) for Blenrep 50 mg/mL is 0173-0913, listed by GlaxoSmithKline LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)